Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$4.15 - $8.37 $103,750 - $209,249
-25,000 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$5.91 - $14.38 $147,750 - $359,500
25,000 New
25,000 $184,000
Q3 2020

Nov 13, 2020

SELL
$14.14 - $19.71 $212,100 - $295,650
-15,000 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$16.6 - $25.25 $249,000 - $378,750
15,000 New
15,000 $284,000

Others Institutions Holding KPTI

About Karyopharm Therapeutics Inc.


  • Ticker KPTI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 79,806,600
  • Market Cap $67M
  • Description
  • Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...
More about KPTI
Track This Portfolio

Track Sg3 Management, LLC Portfolio

Follow Sg3 Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg3 Management, LLC with notifications on news.